Recursion's phase 2 brain disease trial yields scant evidence of efficacy 0 03.09.2024 17:13 Fiercebiotech.com Recursion's phase 2 brain disease trial yields scant evidence of efficacy ntaylor Tue, 09/03/2024 - 10:13
